What's breaking now, across thousands of outlets.
The clearance and broader-than-expected label for Mimrylo open up a yearly revenue opportunity for Takeda that some analysts expect to reach $2 billion or more.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
"...the nature of the design means that it does not need to be reset between jumps. It resets itself."
Assisting an ageing loved one can start with small tasks but may lead to full-time caregiving that requires more support Helping an ageing parent or loved one often begins with easy-to-field requests…
A large observational study indicates that girls fed human milk as infants tend to experience a later onset of puberty compared to those fed exclusively with infant formula, highlighting potential…
Mumbai, August 31, 2026: The Maharashtra Food and Drug Administration (FDA) has temporarily suspended the blood bank licence of Jagjivan Ram Hospital, Mumbai Central, for two days — October 15 and 16…
